The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Spudding of Foum Assaka Well

17 Mar 2014 07:00

RNS Number : 4079C
Fastnet Oil & Gas PLC
17 March 2014
 



Operational Update on Foum Assaka Well FA-1

Fastnet Oil & Gas PLC

 

 

17 March 2014

  

Fastnet Oil & Gas Plc

Operational Update on Foum Assaka Well FA-1, offshore Morocco

 

Fastnet Oil & Gas Plc ("Fastnet") (AIM: FAST, ESM: FOI), the E&P company focused on exploration acreage in Africa and in the Celtic Sea, is pleased to announce that its partner and operator in the Foum Assaka area, offshore Morocco ("Foum Assaka Licence"), Kosmos Energy Deepwater Morocco, a wholly owned subsidiary of Kosmos Energy Ltd. ("Kosmos") (NYSE: KOS), has confirmed that the FA-1 well, located within the Foum Assaka area on the Eagle Prospect, spudded on March 16 2014. Fastnet holds its interest in the Foum Assaka licence area through its wholly owned subsidiary Pathfinder Hydrocarbon Ventures Limited.

 

As previously announced, the planned target depth ("TD") is 4,000 metres in water depth of approximately 600 metres. The well is expected to take up to three months to reach TD and test multiple objectives. The FA-1 well is estimated by the operator, Kosmos, to contain 360 mmboe of Pmean resources in its primary deepwater Lower Cretaceous reservoir objective. Fastnet is carried through its share of the drilling costs, subject to a gross maximum well cost of US$100 million, following the previously announced farm-out to SK Innovation, retaining a 9.375% net interest in the licence.

Commenting, Paul Griffiths, Managing Director of Fastnet, said:

"We are delighted that drilling has commenced on schedule on the Eagle Prospect. The results from the FA-1 well will allow us to further evaluate and potentially de-risk the varied and near-term drilling targets in the Foum Assaka Licence where we and our partners see significant potential upside."

 

For further information, please contact:

 

Fastnet Oil & Gas plc

Cathal Friel, Chairman

Paul Griffiths, Managing Director

+353 (1) 644 0007

 

Shore Capital

Nomad

Bidhi Bhoma, Edward Mansfield

Corporate Broking

Jerry Keen

 

+44 (0) 20 7408 4090

 

GMP Securities Europe LLP

(Joint Broker)

Rob Collins

 

+44 (20) 20 7467 2800

 

Davy

(ESM Adviser & Joint Broker)

John Frain, Anthony Farrell

 

+353 (1) 679 6363

 

Bell Pottinger

Philip Dennis, Rollo Crichton-Stuart, James Lea

 

+44 (0) 207 861 3232

 

Notes to editors

Fastnet Oil & Gas plc is an independent oil and gas exploration company that focuses on identifying early stage exploration and appraisal opportunities in Offshore Ireland and Africa. It is quoted on the AIM market of the London Stock Exchange and the Enterprise Securities Market ("ESM") of the Irish Stock Exchange. Fastnet's aim is to assemble a portfolio of high impact conventional oil and gas assets that will deliver sustainable growth and value for the Company. Its immediate focus is on implementing its Offshore Ireland and Africa strategies where it has been awarded four offshore licensing options in the Celtic Sea (Molly Malone Basin, Shanagarry, 49/13 and Mizzen Basin) and acquired a material interest in the highly prospective Foum Assaka permit Offshore Morocco. In addition, Fastnet will continue to pursue new conventional oil and gas opportunities in Africa where the Directors and Advisory Board also have extensive knowledge, contacts and experience of creating value.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLDELFFZXFBBBZ
Date   Source Headline
19th Feb 202012:00 pmRNSDraft registration statement for US Nasdaq listing
15th Jan 20205:16 pmRNSHolding(s) in Company
15th Jan 20207:00 amRNSAmryt to present updates from its EB research
7th Jan 202012:09 pmRNSPDMR Dealings
30th Dec 201911:07 amRNSHolding(s) in Company
27th Dec 20198:00 amRNSEuronext Growth Dublin Notice
23rd Dec 201911:22 amRNSHolding(s) in Company
20th Dec 20192:40 pmRNSExercise of Warrants & Issue of Ordinary Shares
19th Dec 20197:00 amRNSBusiness integration and synergies on track
26th Nov 20197:00 amRNSHoldings in Company
18th Nov 20197:00 amRNSHoldings in Company
14th Nov 20194:31 pmRNSShare Buyback
5th Nov 20196:16 pmRNSGrant of Options
5th Nov 20197:00 amRNSTrading Update
4th Nov 20197:00 amRNSNotice of Trading Update
28th Oct 20194:58 pmRNSHolding(s) in Company
3rd Oct 20194:38 pmRNSHoldings in Company
1st Oct 20197:00 amRNSAP101 Receives Fast Track Designation from FDA
30th Sep 20194:30 pmRNSHalf-year Report
30th Sep 20197:00 amRNSInvestor Events Update
30th Sep 20197:00 amRNSHolding(s) in Company
25th Sep 20197:00 amRNSCompletion of Acquisition and $60m equity raised
24th Sep 201912:30 pmRNSSchedule One Update - Amryt Pharma Plc
24th Sep 20198:29 amRNSSchedule One Update
24th Sep 20197:30 amRNSSuspension - Amryt Pharma Plc
23rd Sep 20192:15 pmRNSCourt Sanction of the Scheme of Arrangement
20th Sep 20198:00 amRNSEuronext Growth Dublin Notice
19th Sep 20191:30 pmRNSResults of Court Meeting and General Meeting
13th Sep 20197:00 amRNSCircular to Shareholders
11th Sep 20193:00 pmRNSUpdate on Acquisition of Aegerion
5th Sep 20192:30 pmRNSSchedule One - Amryt Pharma plc
5th Sep 20192:30 pmRNSSchedule One
4th Sep 20198:00 amRNSEuronext Growth Dublin Suspension Notice
4th Sep 20197:00 amRNSSuspension of Trading on Euronext
3rd Sep 20191:00 pmRNSHoldings in Company
30th Aug 20193:06 pmRNSHolding(s) in Company
30th Aug 20198:00 amRNSEuronext Growth Dublin Notice
30th Aug 20197:00 amRNSDirector/PDMR Shareholding
27th Aug 20191:00 pmRNSEuronext Growth Dublin Restoration Notice
27th Aug 20191:00 pmRNSRestoration - Amryt Pharma Plc
27th Aug 20191:00 pmRNSPublication of Admission Document and Circular
10th Jul 201911:23 amRNSResult of AGM
12th Jun 20197:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20196:24 pmRNSGrant of Options
21st May 20197:30 amRNSEuronext Growth Dublin Suspension Notice
21st May 20197:30 amRNSSuspension - Amryt Pharma plc
21st May 20197:00 amRNSRecommended Acquisition of Aegerion
17th Apr 20197:00 amRNSPreliminary Results and Q1 Trading Update
12th Apr 201910:04 amRNSNotice of Results
28th Feb 20197:00 amRNSUpdate on AP101 EASE Phase III trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.